The global digital mammography market accounted for USD 1.51 billion in 2023 and is expected to reach at USD 4.43 billion by 2034 with a CAGR of 10.27% during the forecast period 2024-2034. Rising incidence of breast cancer, more screening appointments, widespread adoption of AI technology, growing population of elderly women, increased awareness of these systems, high rates of detection, surge in technological advancements, rising approvals for innovative devices, and growing introduction of new digital mammography devices are some of the key factors boosting the market growth.
Growing introduction of new digital mammography devices is predicted to boost the market growth during the forecast period. Traditional film-based mammography has been replaced by digital mammography systems, primarily due to their multiple benefits. Digital technology permits instant acquisition, display, and storage of high-resolution digital images, enhancing image quality and manipulation options. Moreover, digital mammography facilitates the utilization of computer-aided detection (CAD) systems, aiding radiologists in identifying abnormalities and potential indications of breast cancer. For instance, in November 2023, GE HealthCare introduced the MyBreastAI Suite to enhance breast cancer detection during mammography examinations and simplify radiology processes through the use of artificial intelligence (AI) technology.
By product, 2D full-field digital mammography tomosynthesis was the highest revenue-grossing segment in the global digital mammography market in 2023 owing to their cost-effectiveness & insurance coverage. 2D mammography systems reduce radiation exposure for improved image quality and positioning, leading to clearer images and better outcomes for professionals. 2D mammography is widely adopted as the primary screening method and is recognized as the standard for diagnosing breast cancer in nearly all developed healthcare markets. Additionally, 3D full-field digital mammography tomosynthesis is predicted to grow at the fastest CAGR during the forecast period owing to the increasing trend in breast cancer screening through the use of 3D mammography, surge in the availability of facilities providing this technology and growing introduction of advanced devices. The majority of research suggests that 3D mammography is superior in detecting breast cancer, offering enhanced sensitivity and specificity compared to 2D mammography, especially in cases of higher breast densities. For instance, in September 2023, Siemens Healthineers, a medical device firm, unveiled Mammomat B. brilliant1, a novel tomosynthesis mammography system featuring a wide-angle tube rotating around the breast at a 50° angle, completing scans in approximately five seconds. This technology generates high-resolution 3D images swiftly, facilitating precise identification of tissue abnormalities and microcalcifications with exceptional accuracy.
By end-user, hospitals was the highest revenue-grossing segment in the global digital mammography market in 2023 owing to the presence of advanced systems enhances the patient experience, reduces wait times, & accelerates examinations, growing number of patient population, improved reimbursement policies for breast cancer treatments, and heightened investments in both public & private healthcare sectors. Additionally, diagnostic centers is predicted to grow at the fastest CAGR during the forecast period owing to the increasing accessibility to comprehensive breast imaging services at affordable rates, growing adoption of advanced imaging technologies, the presence of proficient professionals, growing availability of advanced technologies for screening, diagnosing, & planning treatment for high-risk cases, and surge in the introduction of new platforms by industry participants. For instance, in June 2023, UNC Health Pardee has launched a program called "Mammo on the Go," which provides mobile mammography services featuring state-of-the-art early detection capabilities, including 3D digital mammography. This service is available in Buncombe, Polk, and Transylvania counties. The mobile mammography unit is equipped with trained staff and board-certified radiologists.
North America region is anticipated for the highest revenue share during the forecast period owing to the increase in breast cancer cases, substantial research & development efforts in breast cancer treatments, growing advancements in imaging techniques, surge in healthcare expenses, increased investment in breast cancer screening programs, and surge in the introduction of innovative platforms. For instance, in January 2022, With the introduction of Transpara, an AI Breast Care system, ScreenPoint Medical expanded its presence in the United States as well as in 30 countries globally. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising incidence of breast cancer, growing awareness of mammography technologies and increase in cancer screening initiatives undertaken by industry participants. For instance, in November 2023, Fujifilm's Digital Mammography solution aims to conduct 1,500 mammograms nationwide, reaching more than 90,000 women annually. The campaign will be implemented in 19 cities and will utilize 35 diagnostic centers equipped with Fujifilm Amulet mammography solutions.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Growing introduction of new digital mammography devices is predicted to boost the market growth during the forecast period. Traditional film-based mammography has been replaced by digital mammography systems, primarily due to their multiple benefits. Digital technology permits instant acquisition, display, and storage of high-resolution digital images, enhancing image quality and manipulation options. Moreover, digital mammography facilitates the utilization of computer-aided detection (CAD) systems, aiding radiologists in identifying abnormalities and potential indications of breast cancer. For instance, in November 2023, GE HealthCare introduced the MyBreastAI Suite to enhance breast cancer detection during mammography examinations and simplify radiology processes through the use of artificial intelligence (AI) technology.
By product, 2D full-field digital mammography tomosynthesis was the highest revenue-grossing segment in the global digital mammography market in 2023 owing to their cost-effectiveness & insurance coverage. 2D mammography systems reduce radiation exposure for improved image quality and positioning, leading to clearer images and better outcomes for professionals. 2D mammography is widely adopted as the primary screening method and is recognized as the standard for diagnosing breast cancer in nearly all developed healthcare markets. Additionally, 3D full-field digital mammography tomosynthesis is predicted to grow at the fastest CAGR during the forecast period owing to the increasing trend in breast cancer screening through the use of 3D mammography, surge in the availability of facilities providing this technology and growing introduction of advanced devices. The majority of research suggests that 3D mammography is superior in detecting breast cancer, offering enhanced sensitivity and specificity compared to 2D mammography, especially in cases of higher breast densities. For instance, in September 2023, Siemens Healthineers, a medical device firm, unveiled Mammomat B. brilliant1, a novel tomosynthesis mammography system featuring a wide-angle tube rotating around the breast at a 50° angle, completing scans in approximately five seconds. This technology generates high-resolution 3D images swiftly, facilitating precise identification of tissue abnormalities and microcalcifications with exceptional accuracy.
By end-user, hospitals was the highest revenue-grossing segment in the global digital mammography market in 2023 owing to the presence of advanced systems enhances the patient experience, reduces wait times, & accelerates examinations, growing number of patient population, improved reimbursement policies for breast cancer treatments, and heightened investments in both public & private healthcare sectors. Additionally, diagnostic centers is predicted to grow at the fastest CAGR during the forecast period owing to the increasing accessibility to comprehensive breast imaging services at affordable rates, growing adoption of advanced imaging technologies, the presence of proficient professionals, growing availability of advanced technologies for screening, diagnosing, & planning treatment for high-risk cases, and surge in the introduction of new platforms by industry participants. For instance, in June 2023, UNC Health Pardee has launched a program called "Mammo on the Go," which provides mobile mammography services featuring state-of-the-art early detection capabilities, including 3D digital mammography. This service is available in Buncombe, Polk, and Transylvania counties. The mobile mammography unit is equipped with trained staff and board-certified radiologists.
North America region is anticipated for the highest revenue share during the forecast period owing to the increase in breast cancer cases, substantial research & development efforts in breast cancer treatments, growing advancements in imaging techniques, surge in healthcare expenses, increased investment in breast cancer screening programs, and surge in the introduction of innovative platforms. For instance, in January 2022, With the introduction of Transpara, an AI Breast Care system, ScreenPoint Medical expanded its presence in the United States as well as in 30 countries globally. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising incidence of breast cancer, growing awareness of mammography technologies and increase in cancer screening initiatives undertaken by industry participants. For instance, in November 2023, Fujifilm's Digital Mammography solution aims to conduct 1,500 mammograms nationwide, reaching more than 90,000 women annually. The campaign will be implemented in 19 cities and will utilize 35 diagnostic centers equipped with Fujifilm Amulet mammography solutions.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Product and End-user
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of Top 10+ Major Market Players
Segmentation: Digital Mammography Market Report 2023 - 2034
Digital Mammography Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- 3D Full Field Digital Mammography Tomosynthesis
- 2D Full Field Digital Mammography Tomosynthesis
Digital Mammography Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Hospitals
- Diagnostic Centers
- Others
Digital Mammography Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Digital Mammography Market: Product Estimates & Trend Analysis
8. Digital Mammography Market: End-user Estimates & Trend Analysis
9. Regional Market Analysis
10. North America Digital Mammography Market
11. Europe Global Digital Mammography Market
12. Asia Pacific Global Digital Mammography Market
13. Latin America Global Digital Mammography Market
14. MEA Global Digital Mammography Market
15. Competitor Analysis
16. Company Profiles
Companies Mentioned
- Hologic Inc.
- GE Healthcare
- PLANMED OY
- Metaltronica S.p.A
- Fujifilm Corporation
- Koninklijke Philips NV
- Toshiba Medical Systems
- Siemens Healthcare GmBH
